MedPath

Study on Female Patients' Mammographic Texture Features

Not Applicable
Not yet recruiting
Conditions
Breast Cancer
Artificial Intelligence
Mammography
Interventions
Device: AI tool
Registration Number
NCT06469606
Lead Sponsor
Tampere University Hospital
Brief Summary

Mammography is the most common method for breast imaging, and it provides information for model building and analysis. Radiomics applied to mammography has the potential to revolutionize clinical decision-making by providing valuable insights into risk assessment and disease detection. Despite this, the influence of imaging parameters and clinical and biological factors on radiological texture features remains poorly understood. There is a pressing need to overcome the obstacle of system-inherent effects on mammographic images to facilitate the translation of radiological texture features into routine clinical practice by enabling reliable and robust AI-based or AI-aided decision-making. Furthermore, understanding the relationship between imaging parameters, textural features, and clinical and biological information supports the clinical use of AI. The objective of this study is to evaluate AI methods for clinical practice and to study how it relates to clinical factors and biological features.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Candidate is a biological female aged 18 years or above;
  • Candidate is willing and able to give informed consent and gives their written consent for the participation in the study;
  • There is a clinical indication for a uni- or bilateral mastectomy
Exclusion Criteria
  • Candidate lacks the capacity to provide informed consent;
  • Candidate has breast implants

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Participant diagnosed with breast cancerAI toolParticipants diagnosed with breast cancer who will undergo a mastectomy operation
Participant not diagnosed with breast cancerAI toolParticipants who will undergo a mastectomy operation for a non-breast cancer related clinical indication
Primary Outcome Measures
NameTimeMethod
Mammographic texture featuresThrough study completion, an average of 5 year

Aim: to evaluate how imaging parameters affect the mammographic texture features

Secondary Outcome Measures
NameTimeMethod
Biological featuresthrough study completion, an average of 10 year

Aim: To evaluate whether there is an interplay between mammographic texture feature parameters and pathological and biological features (e.g., breast cancer biomarkers)

© Copyright 2025. All Rights Reserved by MedPath